Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase II, controlled, randomized, single blind study to evaluate the immunogenicity, safety and reactogenicity of the low dose influenza vaccine adjuvanted with AS03 compared to Fluarix™ (GlaxoSmithKline Biologicals) administered intramuscularly in elderly 60 years and older https://www.kusajili.com:443/Trial/BsUCRon5D0eUZhII7GVYJA%24a-phase-ii-controlled-randomized-single-blind-study-to-evaluate-the-immunogenicity-safety-and-reactogenicity-of-the-low-dose-in
I have read and accept the terms of use of the site and the Privacy Policy
Send your message